US5470997A
(en)
*
|
1992-04-06 |
1995-11-28 |
Biosite Diagnostics Incorporated |
Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
|
AU3941893A
(en)
*
|
1992-04-06 |
1993-11-08 |
Biosite Diagnostics Incorporated |
Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
|
CA2096495C
(en)
*
|
1992-06-16 |
2002-07-09 |
Kathy Palmer Ordonez |
Dual analyte immunoassay
|
US6037455A
(en)
*
|
1992-11-09 |
2000-03-14 |
Biosite Diagnostics Incorporated |
Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels
|
US5804452A
(en)
*
|
1995-04-27 |
1998-09-08 |
Quidel Corporation |
One step urine creatinine assays
|
US5965375A
(en)
*
|
1997-04-04 |
1999-10-12 |
Biosite Diagnostics |
Diagnostic tests and kits for Clostridium difficile
|
DE19859912C2
(de)
*
|
1998-12-23 |
2001-06-21 |
Aventis Res & Tech Gmbh & Co |
Testsystem zur Erkennung verschiedener Marker, seine Herstellung sowie Verwendung
|
CA2399202A1
(en)
*
|
2000-03-09 |
2001-09-13 |
Heska Corporation |
Use of recombinant antigens to determine the immune status of an animal
|
US20020110843A1
(en)
*
|
2000-05-12 |
2002-08-15 |
Dumas David P. |
Compositions and methods for epitope mapping
|
JP4986370B2
(ja)
|
2000-12-22 |
2012-07-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
Rgmおよびそのモジュレーターの用途
|
US7632647B2
(en)
*
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
US20040121350A1
(en)
*
|
2002-12-24 |
2004-06-24 |
Biosite Incorporated |
System and method for identifying a panel of indicators
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US20040203083A1
(en)
*
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
US20040126767A1
(en)
*
|
2002-12-27 |
2004-07-01 |
Biosite Incorporated |
Method and system for disease detection using marker combinations
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
EP2261669A1
(de)
|
2001-05-04 |
2010-12-15 |
Alere San Diego, Inc. |
Diagnostischer Marker akuter Koronarsyndrome und Verfahren zu deren Verwendung
|
DE10125258A1
(de)
|
2001-05-23 |
2003-01-09 |
November Ag Molekulare Medizin |
Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden
|
JP2005522669A
(ja)
*
|
2001-08-20 |
2005-07-28 |
バイオサイト インコーポレイテッド |
卒中および脳損傷の診断マーカーおよびその使用方法
|
US6780602B2
(en)
*
|
2001-11-01 |
2004-08-24 |
Microbiosystems, Limited Partnership |
Taxonomic identification of pathogenic microorganisms and their toxic proteins
|
US7459127B2
(en)
|
2002-02-26 |
2008-12-02 |
Siemens Healthcare Diagnostics Inc. |
Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
|
US7125711B2
(en)
|
2002-12-19 |
2006-10-24 |
Bayer Healthcare Llc |
Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
|
US7094354B2
(en)
|
2002-12-19 |
2006-08-22 |
Bayer Healthcare Llc |
Method and apparatus for separation of particles in a microfluidic device
|
EP1616181B1
(de)
|
2003-04-17 |
2009-08-12 |
Vermillion, Inc. |
Mit natriuretischen peptiden verwandte polypeptide und verfahren zu ihrer identifizierung und verwendung
|
US7435381B2
(en)
|
2003-05-29 |
2008-10-14 |
Siemens Healthcare Diagnostics Inc. |
Packaging of microfluidic devices
|
US20040265171A1
(en)
*
|
2003-06-27 |
2004-12-30 |
Pugia Michael J. |
Method for uniform application of fluid into a reactive reagent area
|
US7347617B2
(en)
|
2003-08-19 |
2008-03-25 |
Siemens Healthcare Diagnostics Inc. |
Mixing in microfluidic devices
|
CA2537668A1
(en)
*
|
2003-09-29 |
2005-04-14 |
Biosite Incorporated |
Methods and compositions for the diagnosis of sepsis
|
US6991911B2
(en)
*
|
2003-12-15 |
2006-01-31 |
Dade Behring Inc. |
Assay for entactogens
|
US7022492B2
(en)
*
|
2003-12-15 |
2006-04-04 |
Dade Behring Inc. |
Ecstasy haptens and immunogens
|
US20050130243A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Zheng Yi F. |
Assay for entactogens
|
US7037669B2
(en)
*
|
2004-03-22 |
2006-05-02 |
Dade Behring Inc. |
Assays for amphetamine and methamphetamine using stereospecific reagents
|
US7115383B2
(en)
*
|
2004-03-22 |
2006-10-03 |
Dade Behring Inc. |
Assays for amphetamine and methamphetamine
|
CA2579370A1
(en)
*
|
2004-09-09 |
2006-03-23 |
Biosite Incorporated |
Methods and compositions for measuring canine bnp and uses thereof
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US7879979B2
(en)
*
|
2005-01-21 |
2011-02-01 |
Alere International |
Arginine analogs, and methods for their synthesis and use
|
US7939342B2
(en)
*
|
2005-03-30 |
2011-05-10 |
Kimberly-Clark Worldwide, Inc. |
Diagnostic test kits employing an internal calibration system
|
EP1715341B1
(de)
*
|
2005-04-04 |
2008-02-27 |
Micronas Holding GmbH |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von mindestens zwei Liganden
|
US20070087453A1
(en)
*
|
2005-10-19 |
2007-04-19 |
Council Of Scientific And Industrial Research |
Immuno conjugate and process for preparation thereof
|
WO2007028070A2
(en)
*
|
2005-08-30 |
2007-03-08 |
Biosite, Inc. |
Use of soluble flt-1 and its fragments in cardiovascular conditions
|
JP2009510002A
(ja)
|
2005-09-30 |
2009-03-12 |
アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
反発誘導分子(rgm)タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
|
EP2005168A4
(de)
*
|
2006-03-09 |
2009-05-20 |
Biosite Inc |
Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
|
EP1845377A1
(de)
|
2006-04-10 |
2007-10-17 |
Micronas GmbH |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von Liganden
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
GB0611116D0
(en)
|
2006-06-06 |
2006-07-19 |
Oxford Genome Sciences Uk Ltd |
Proteins
|
WO2007142540A1
(en)
|
2006-06-07 |
2007-12-13 |
Otago Innovation Limited |
Diagnostic methods and markers
|
WO2008094198A2
(en)
*
|
2006-07-28 |
2008-08-07 |
Biosite Incorporated |
Devices and methods for performing receptor binding assays using magnetic particles
|
CN101611318B
(zh)
|
2006-09-07 |
2015-03-04 |
奥塔哥创新有限公司 |
生物标记物
|
DE502006005987D1
(de)
*
|
2006-10-20 |
2010-03-11 |
Micronas Holding Gmbh |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von Liganden
|
WO2008061149A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
WO2008060607A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US8221995B2
(en)
*
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US7947465B2
(en)
*
|
2007-08-20 |
2011-05-24 |
Bio-Rad Laboratories, Inc. |
Simultaneous assay for determining drugs
|
US20090053832A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Link William F |
Simultaneous assay for determining drugs
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
WO2009113879A1
(en)
|
2008-03-12 |
2009-09-17 |
Christopher Joseph Pemberton |
Biomarkers
|
JP2011516038A
(ja)
|
2008-03-12 |
2011-05-26 |
オタゴ イノベーション リミテッド |
バイオマーカー
|
BRPI0917711A2
(pt)
|
2008-08-28 |
2017-06-20 |
Astute Medical Inc |
método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal
|
WO2010025434A1
(en)
|
2008-08-29 |
2010-03-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2740923A1
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3974836A1
(de)
|
2008-10-21 |
2022-03-30 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
BRPI0922021A2
(pt)
|
2008-11-10 |
2019-09-24 |
Astute Medical Inc |
método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
|
NZ604873A
(en)
|
2008-11-22 |
2014-05-30 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US20100204055A1
(en)
*
|
2008-12-05 |
2010-08-12 |
Bonner-Ferraby Phoebe W |
Autoantibody detection systems and methods
|
JP5981144B2
(ja)
|
2009-02-06 |
2016-08-31 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断
|
NZ594771A
(en)
|
2009-02-06 |
2013-06-28 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and failure
|
CA2767616A1
(en)
|
2009-07-09 |
2011-01-13 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
EP2462446B1
(de)
|
2009-08-07 |
2017-09-27 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
EP2462440B1
(de)
|
2009-08-07 |
2017-05-17 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
JP5775874B2
(ja)
|
2009-08-28 |
2015-09-09 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
JP2013513086A
(ja)
|
2009-09-18 |
2013-04-18 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
NZ599105A
(en)
|
2009-09-21 |
2014-08-29 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EA201290192A1
(ru)
|
2009-11-07 |
2013-02-28 |
Астьют Медикал, Инк. |
Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
|
MX2012005210A
(es)
|
2009-11-07 |
2012-08-03 |
Astute Medical Inc |
Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal.
|
EP2510001B1
(de)
|
2009-12-08 |
2015-12-02 |
AbbVie Deutschland GmbH & Co KG |
Monoklonale antikörper gegen das rgm-a-protein zur behandlung von degenerationen der retinalen nervenfaserschicht
|
CA2784889C
(en)
|
2009-12-20 |
2018-06-19 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CN102884205B
(zh)
|
2010-02-05 |
2016-05-04 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
WO2011097540A1
(en)
|
2010-02-05 |
2011-08-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
NZ700695A
(en)
|
2010-02-05 |
2016-05-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US9029093B2
(en)
|
2010-02-26 |
2015-05-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
EP2899545B1
(de)
|
2010-06-23 |
2018-08-22 |
Astute Medical, Inc. |
Verfahren zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
EP2585825B1
(de)
|
2010-06-23 |
2018-01-10 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
AU2011269775B2
(en)
|
2010-06-23 |
2015-01-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
ES2629850T3
(es)
|
2010-07-19 |
2017-08-16 |
Otago Innovation Limited |
Biomarcadores de señal
|
CN106248921A
(zh)
|
2010-09-24 |
2016-12-21 |
阿斯图特医药公司 |
利用透明质酸评价肾损伤的方法和组合物
|
US10557856B2
(en)
|
2010-09-24 |
2020-02-11 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Biomarkers of renal injury
|
JP2013539861A
(ja)
|
2010-10-07 |
2013-10-28 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
CN103370619B
(zh)
|
2010-11-29 |
2016-01-20 |
美艾利尔圣地亚哥有限公司 |
诊断或风险预测心力衰竭的方法和试剂
|
WO2012094658A2
(en)
|
2011-01-08 |
2012-07-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2668497B1
(de)
|
2011-01-26 |
2020-03-25 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Urinbiomarker zur vorhersage der erholung nach einer akuten nierenverletzung: proteomik
|
WO2012103450A2
(en)
|
2011-01-29 |
2012-08-02 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3489690A1
(de)
|
2011-08-26 |
2019-05-29 |
Astute Medical, Inc. |
Methoden und zusammensetzungen für die evaluierung des nierenstatus
|
IN2014MN00949A
(de)
|
2011-11-22 |
2015-04-24 |
Astute Medical Inc |
|
ES2734494T3
(es)
|
2011-12-08 |
2019-12-10 |
Astute Medical Inc |
Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
|
AU2012352168C1
(en)
|
2011-12-14 |
2018-01-25 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
US9636398B2
(en)
|
2011-12-14 |
2017-05-02 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
PL2807192T3
(pl)
|
2012-01-27 |
2019-02-28 |
Abbvie Deutschland |
Kompozycja oraz sposób diagnostyki i leczenia chorób związanych ze zwyrodnieniem neurytów
|
CA2865563A1
(en)
|
2012-02-27 |
2013-09-06 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2825891A1
(de)
|
2012-03-13 |
2015-01-21 |
AbbVie Inc. |
Verfahren zur auswahl oder identifikation einer person für eine v1b-antagonisten-therapie
|
CN104470942B
(zh)
|
2012-03-20 |
2018-12-14 |
奥塔哥创新有限公司 |
生物标志物
|
US20150293131A1
(en)
|
2012-04-02 |
2015-10-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of sepsis
|
WO2013163345A1
(en)
|
2012-04-24 |
2013-10-31 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
|
US20150177260A1
(en)
|
2012-07-23 |
2015-06-25 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of sepsis
|
EP2882767B1
(de)
|
2012-08-11 |
2023-07-12 |
Astute Medical, Inc. |
Bewertung von nierenläsionen mithilfe von hyaluronsäure
|
CA3158996A1
(en)
|
2013-01-17 |
2014-07-24 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US9694069B2
(en)
|
2013-03-14 |
2017-07-04 |
Alere San Diego, Inc. |
6-acetylmorphine analogs, and methods for their synthesis and use
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
WO2014197729A1
(en)
|
2013-06-05 |
2014-12-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2014197885A2
(en)
|
2013-06-07 |
2014-12-11 |
Duke University |
Inhibitors of complement factor h
|
MX2016001573A
(es)
|
2013-08-07 |
2016-09-07 |
Astute Medical Inc |
Ensayos para timp2 con mejor rendimiento en muestras biológicas.
|
MX2016002375A
(es)
|
2013-08-23 |
2016-12-20 |
Reata Pharmaceuticals Inc |
Métodos de tratamiento y prevencion de la disfunción endotelial utilizando metil bardoxololona o sus análogos.
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
WO2015179773A1
(en)
|
2014-05-22 |
2015-11-26 |
The Scripps Research Institute |
Tissue molecular signatures of kidney transplant rejections
|
US10794917B2
(en)
|
2013-09-20 |
2020-10-06 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
|
CA2929547C
(en)
|
2013-11-06 |
2023-02-28 |
Astute Medical, Inc. |
Assays for igfbp7 having improved performance in biological samples
|
WO2015084939A1
(en)
|
2013-12-03 |
2015-06-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2934878A1
(en)
|
2013-12-30 |
2015-07-09 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Genomic rearrangements associated with prostate cancer and methods of using the same
|
EP3825418A3
(de)
|
2014-05-22 |
2021-09-15 |
The Scripps Research Institute |
Molekulare signaturen zur unterscheidung von lebertransplantatabstossungen oder -verletzungen
|
WO2015179777A2
(en)
|
2014-05-22 |
2015-11-26 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
BR112017008218A2
(pt)
|
2014-10-20 |
2018-01-09 |
Astute Medical Inc |
métodos e composições para diagnóstico e prognóstico de lesão renal e insuficiência renal
|
ES2943579T3
(es)
|
2014-12-18 |
2023-06-14 |
Astute Medical Inc |
Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
|
US11243202B2
(en)
|
2015-04-09 |
2022-02-08 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3294416A4
(de)
|
2015-05-12 |
2018-11-21 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
US11506672B2
(en)
|
2015-06-11 |
2022-11-22 |
Astute Medical, Inc. |
Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
|
WO2016205740A1
(en)
|
2015-06-17 |
2016-12-22 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
|
CA2992139A1
(en)
|
2015-07-10 |
2017-01-19 |
West Virginia University |
Markers of stroke and stroke severity
|
US11209431B2
(en)
|
2015-10-06 |
2021-12-28 |
Bio-Rad Laboratories, Inc. |
Borrelia immunoassays and materials therefor
|
AU2017267728B2
(en)
|
2016-05-18 |
2021-11-04 |
Alere San Diego, Inc. |
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
|
CN109844526A
(zh)
|
2016-06-06 |
2019-06-04 |
机敏医药股份有限公司 |
使用胰岛素样生长因子结合蛋白7和金属蛋白酶2的组织抑制剂管理急性肾损伤
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
JP2019535015A
(ja)
|
2016-10-03 |
2019-12-05 |
アボット・ラボラトリーズAbbott Laboratories |
患者サンプルにおけるgfap状況を評価する改善された方法
|
EP3522893A4
(de)
|
2016-10-04 |
2020-08-26 |
University Of Maryland, Baltimore |
Verfahren zur behandlung von sepsis unter verwendung von therapeutika auf der basis von anti-sepsis-lipid a (asla)
|
KR102486434B1
(ko)
|
2016-11-08 |
2023-01-09 |
리아타 파마슈티컬즈 홀딩스, 엘엘씨 |
바독솔론 메틸 또는 이의 유사체를 사용하는 알포트 증후군의 치료 방법
|
JP2020504157A
(ja)
|
2017-01-12 |
2020-02-06 |
アスチュート メディカル,インコーポレイテッド |
C−cモチーフケモカインリガンド14の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物
|
US20200041492A1
(en)
|
2017-03-09 |
2020-02-06 |
Rijksuniversiteit Groningen |
Biomarkers for cellular senescence
|
WO2018175942A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
US10877048B2
(en)
|
2017-04-15 |
2020-12-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
WO2018208684A1
(en)
|
2017-05-07 |
2018-11-15 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|
BR112019024701A2
(pt)
|
2017-05-25 |
2020-06-09 |
Abbott Lab |
métodos para auxiliar na determinação se um exame de imagem deve ser realizado em um indivíduo humano que sofreu ou pode ter sofrido uma lesão na cabeça com o uso de biomarcadores precoces
|
CA3059601A1
(en)
|
2017-05-30 |
2018-12-06 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
JP7379165B2
(ja)
|
2017-12-09 |
2023-11-14 |
アボット・ラボラトリーズ |
Gfapとuch-l1との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
US11891439B2
(en)
|
2017-12-28 |
2024-02-06 |
Astute Medical, Inc. |
Antibodies and assays for CCL14
|
WO2019133717A1
(en)
|
2017-12-29 |
2019-07-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
US20210239700A1
(en)
|
2018-05-04 |
2021-08-05 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
EP4043015A1
(de)
|
2018-09-04 |
2022-08-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Delta-tocotrienol zur behandlung von krebs
|
CN113454455A
(zh)
|
2018-12-28 |
2021-09-28 |
雅培制药有限公司 |
微粒上的单分子的直接检测
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
WO2020180695A1
(en)
|
2019-03-01 |
2020-09-10 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
AU2021273460A1
(en)
|
2020-05-09 |
2022-12-08 |
Reata Pharmaceuticals Holdings, LLC |
Methods of treating covid-19 using bardoxolone methyl or analogs thereof
|
MX2022015287A
(es)
|
2020-06-01 |
2023-02-22 |
Loop Diagnostics S L |
Metodo y kit para la deteccion temprana de septicemia.
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
JP2023536737A
(ja)
|
2020-08-04 |
2023-08-29 |
アボット・ラピッド・ダイアグノスティクス・インターナショナル・アンリミテッド・カンパニー |
Sars-cov-2を検出するためのアッセイ
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022126129A1
(en)
|
2020-12-11 |
2022-06-16 |
Reata Pharmaceuticals, Inc. |
Synthetic triterpenoids for use in therapy
|
EP4271998A1
(de)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
|
AU2022279156A1
(en)
|
2021-05-18 |
2023-11-02 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
AU2022293389A1
(en)
|
2021-06-14 |
2024-01-04 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
WO2023129942A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023212293A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Complement factor h related 4-specific antibodies and uses thereof
|
WO2023212294A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
WO2023212298A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Bispecific antibodies and methods of treating ocular disease
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|